Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:caused_by |
gptkb:Hepatitis_B_virus
|
| gptkbp:complications |
hepatic encephalopathy
liver failure portal hypertension |
| gptkbp:current_use |
gptkb:hepatocellular_carcinoma
liver fibrosis hepatitis D virus infection |
| gptkbp:healthcare |
in many countries
can lead to liver cancer can lead to liver cirrhosis |
| https://www.w3.org/2000/01/rdf-schema#label |
Hepatitis B
|
| gptkbp:incubation_period |
30 to 180 days
|
| gptkbp:is_popular_in |
approximately 257 million people infected
|
| gptkbp:is_protected_by |
vaccination
safe sex practices needle exchange programs screening pregnant women |
| gptkbp:is_vulnerable_to |
gptkb:Hepatitis_B_vaccine
|
| gptkbp:recommendation |
screening blood donations
universal vaccination of infants education on transmission and prevention |
| gptkbp:risk_factor |
sharing needles
unprotected sex healthcare workers people who inject drugs people with multiple sexual partners exposure to infected blood mother with hepatitis B people with HIV |
| gptkbp:screenings |
recommended for high-risk groups
|
| gptkbp:social_responsibility |
blood test
can resolve spontaneously can be asymptomatic |
| gptkbp:symptoms |
fatigue
nausea abdominal pain jaundice loss of appetite |
| gptkbp:transmission |
gptkb:healthcare_organization
sexual contact mother to child |
| gptkbp:treatment |
liver transplant
antiviral medications regular follow-up care interferon therapy monitoring liver function nucleos(t)ide analogs |
| gptkbp:was_marked_by |
H Bs Ag
anti-H Bc anti-H Bs |
| gptkbp:bfsParent |
gptkb:HIV
gptkb:Gilead_Sciences,_Inc. |
| gptkbp:bfsLayer |
4
|